サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ガラス化法市場- 成長、将来展望、競合分析、2023～2031年
市場調査レポート
商品コード
1422163

ガラス化法市場- 成長、将来展望、競合分析、2023～2031年

Vitrification Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日
ページ情報
英文 110 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ガラス化法市場- 成長、将来展望、競合分析、2023～2031年
出版日: 2024年01月24日
発行: Acute Market Reports
ページ情報: 英文 110 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ガラス化法市場は、2024年から2032年の予測期間中にCAGR 17％で成長すると予測されます。同市場の成長には、ARTの進歩、体外受精の需要増加、妊孕性温存の受容拡大が寄与しています。しかし、倫理的・法的な配慮が大きな制約となるため、業界はこれらの複雑な問題を責任を持って乗り切る必要があります。検体、最終用途、地域力学に基づく市場セグメンテーションは、多様なニーズや地域差への適応性を反映しています。Vitrolife AB社、Irvine Scientific社、CooperSurgical社などの主要企業は、イノベーション、コラボレーション、事業拡大を重視し、市場でのリーダーシップを維持するための戦略を示しています。ガラス化法市場が進化を続ける中、戦略的コラボレーション、技術の進歩、倫理的実践へのコミットメントは、生殖補助医療技術の未来を形作る上で極めて重要な役割を果たすと思われます。個人とカップルの多様なニーズを満たすことに重点を置く業界は、生殖医療と家族形成を支援し、ヘルスケアと福祉のより広範な情勢に貢献するという役割を強調しています。

生殖補助医療（ART）の進歩：ガラス化法イノベーションをリードする

ガラス化法市場は生殖補助医療技術（ART）の絶え間ない進歩によって支えられており、卵母細胞、胚、精子がその牽引役となっています。凍結保存技術やガラス化法プロトコルの革新により、不妊治療の成功率は著しく向上しています。臨床研究や業界報告から、不妊治療の選択肢を広げる上で、これらの進歩が極めて重要な役割を担っていることが明らかになっています。2024年から2032年までの予測期間中、この分野で最も高い年間平均成長率（CAGR）が予想されるが、これは生殖過程のさまざまな段階においてガラス化法の採用が増加していることを反映しています。同市場は、卵子、胚、精子のガラス化法における技術的ブレークスルーを活用することで、不妊治療における精度と効果に対する需要の高まりに対応しています。

体外受精（IVF）処置の需要増加：需要の高まりに対応する体外受精クリニックとバイオバンク

ガラス化法市場は、体外受精（IVF）処置の需要増加により力強い成長を遂げており、IVFクリニックとバイオバンクが重要な役割を果たしています。患者統計や業界分析から、体外受精治療を求める患者が急増しており、信頼性の高い凍結保存方法の必要性が高まっていることが実証されています。2023年には、IVFクリニックが最も高い売上高を計上したが、これは不妊治療サービス提供における中心的地位を反映しています。しかし、2024年から2032年までの予測期間中に最も高いCAGRが予想されるのはバイオバンク分野であり、これは臨床の場を超えた不妊治療保存の進化を示すものです。市場は人口動態やライフスタイルの変化に適応し、IVFクリニックとバイオバンクを生殖補助医療技術の需要拡大に対応する重要な貢献者と位置づけています。

拡大する妊孕性温存の受容：社会動向と技術意識の変化

ガラス化法市場は、社会動向の変化と技術意識の高まりに影響された妊孕性温存の受容拡大によって牽引されています。公衆衛生の取り組みや家族計画に対する考え方の変化から、妊孕性温存の選択肢に対する認識が高まっていることが裏付けられます。2024年から2032年までの予測期間中、この分野で最も高いCAGRが予想されるが、これは個人とカップルの進化するニーズへの市場の対応を反映しています。妊孕性温存に対する意識が高まるにつれ、生殖能力を守るためにガラス化法を選択する人が増えています。市場は変化する社会規範に沿い、医学的、個人的、またはライフスタイル上の理由から妊孕性を温存しようとする個人に解決策を提供します。

倫理的・法的考察：技術の進歩と倫理基準のバランス

ガラス化法市場における重大な抑制要因は、倫理的・法的考察に関連しています。規制の枠組みや倫理的ガイドラインから、生殖補助医療技術を取り巻く複雑さが浮き彫りになっています。2024年から2032年までの予測期間中、この分野で最も高いCAGRが見込まれており、業界が倫理的・法的課題を効果的に乗り切る必要性が強調されています。市場が進化し続けるにつれ、技術の進歩と倫理基準の遵守のバランスを保つことが極めて重要になってくる。この抑制要因に対する市場の対応としては、責任ある包括的な実践を確保するために、規制機関、倫理委員会、利害関係者との継続的な対話が含まれます。業界は、不妊治療とガラス化法技術の未来を形作る上で倫理的配慮が重要であることを認識しています。

検体別の市場分析：卵母細胞ガラス化法が市場を独占

ガラス化法市場は、卵子、胚、精子などの検体に基づいてセグメント化されます。2023年、最も高い収益を上げたのは卵母細胞のガラス化法でした。しかし、2024年から2032年までの予測期間中に最もCAGRが高いのは胚ガラス化法セグメントであり、生殖補助医療技術の進化を示すものです。この市場は、卵子、胚、精子のための包括的なソリューションを提供することによって、多様な妊孕性温存のニーズに対応しています。女性の生殖能力を維持することから男性の生殖オプションを強化することまで、市場のセグメンテーションは個人やカップルの多様なニーズを満たす多用途性を反映しています。

最終用途別市場分析：体外受精クリニックが市場を独占

ガラス化法市場は、IVFクリニックやバイオバンクなど、最終用途に基づいてさらに細分化されます。2023年には、IVFクリニックが不妊治療とガラス化法サービスの主要拠点として収益を牽引しました。しかし、2024年から2032年までの予測期間において最もCAGRが高いのはバイオバンク分野であり、これは臨床の枠を超えて不妊治療におけるバイオバンクの役割が拡大していることを示しています。同市場は、IVFクリニックとバイオバンクの両方と連携することで、個人やカップルの多様なニーズに対応し、妊孕性温存サービスにおけるアクセシビリティと柔軟性を確保しています。業界が発展するにつれて、IVFクリニックとバイオバンクのパートナーシップは、ガラス化法サービスの将来の情勢を形成する上で極めて重要になります。

北米が世界のリーダーであり続ける

ガラス化法市場は、地域によって最高CAGRと売上比率が異なるなど、多様な地域的動向を示しています。市場分析と地域別の成長パターンから、世界市場のダイナミクスが明らかになった。2023年には、北米が不妊治療の高い普及率と先進ヘルスケアインフラに牽引され、売上高をリードしました。しかし、2024年から2032年までの予測期間中にCAGRが最も高い地域はアジア太平洋であり、新たな機会と進化する動向を示しています。市場の地理的セグメンテーションは、規制の枠組み、文化的ニュアンス、ヘルスケアへのアクセスなどの要因を考慮し、地域の成長を活かそうとする市場プレーヤーに戦略的洞察を提供します。

市場競争は予測期間中に激化へ

ガラス化法市場は激しい競争を特徴としており、主要企業は市場の主導権を維持するためにさまざまな戦略を採用しています。2023年には、Vitrolife AB、Irvine Scientific、CooperSurgical、Genea Biomedx、NidaCon International AB、Minitube、IMV Technologies Group、FUJIFILM Corporation、Biotech, Inc、Kitazato Corporation、Shenzhen VitaVitro Biotechなどの著名企業が、好調な業績と市場での存在感を示しました。これらの企業は、多様なガラス化法ソリューションを提供し、プロトコルの有効性を高めるための研究開発に投資し、不妊治療クリニックや研究機関との提携を確立することで、戦略的なポジションを確立しました。2023年に最も収益が高かったこれらの企業は業界リーダーであり、2024年から2032年までの予測期間において期待される戦略には、製品ポートフォリオのさらなる拡大、地理的拡大、進化する市場ニーズに対応するための共同イニシアティブなどが含まれます。市場の競合情勢は、主要企業間の絶え間ない革新と差別化によって特徴付けられ、生殖の旅路にある個人やカップルのダイナミックなニーズを満たす活気に満ちた進化する業界を保証しています。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 ガラス化法市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2023 vs 2032

第4章 ガラス化法市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のガラス化法市場金額 2022-2032
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済情勢
    • テクノロジーの情勢
    • 法的情勢
    • 社会的情勢

第5章 ガラス化法市場：検体別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 卵母細胞
      • デバイス
      • キットと消耗品
    • 胚
      • デバイス
      • キットと消耗品
    • 精子

第6章 ガラス化法市場：最終用途別 2022-2032

  • 市場概要
  • 成長・収益分析：2023 vs 2032
  • 数量と価格の分析2022-2032
  • 市場セグメンテーション
    • 体外受精クリニック
    • バイオバンク

第7章 北米のガラス化法市場 2022-2032

  • 市場概要
  • ガラス化法市場：検体別 2022-2032
  • ガラス化法市場：最終用途別 2022-2032
  • ガラス化法市場：地域別 2022-2032
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第8章 英国と欧州連合のガラス化法市場 2022-2032

  • 市場概要
  • ガラス化法市場：検体別 2022-2032
  • ガラス化法市場：最終用途別 2022-2032
  • ガラス化法市場：地域別 2022-2032
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第9章 アジア太平洋のガラス化法市場 2022-2032

  • 市場概要
  • ガラス化法市場：検体別 2022-2032
  • ガラス化法市場：最終用途別 2022-2032
  • ガラス化法市場：地域別 2022-2032
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第10章 ラテンアメリカのガラス化法市場 2022-2032

  • 市場概要
  • ガラス化法市場：検体別 2022-2032
  • ガラス化法市場：最終用途別 2022-2032
  • ガラス化法市場：地域別 2022-2032
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第11章 中東・アフリカのガラス化法市場 2022-2032

  • 市場概要
  • ガラス化法市場：検体別 2022-2032
  • ガラス化法市場：最終用途別 2022-2032
  • ガラス化法市場：地域別 2022-2032
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第12章 企業プロファイル

  • Vitrolife AB
  • Irvine Scientific
  • CooperSurgical
  • Genea Biomedx
  • NidaCon International AB
  • Minitube
  • IMV Technologies Group
  • FUJIFILM Corporation
  • Biotech Inc.
  • Kitazato Corporation
  • Shenzhen VitaVitro Biotech
  • その他の主要企業
図表

List of Tables

  • TABLE 1 Global Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 2 Global Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 3 Global Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 4 Global Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 5 North America Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 6 North America Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 7 North America Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 8 North America Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 9 U.S. Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 10 U.S. Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 11 U.S. Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 12 U.S. Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 13 Canada Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 14 Canada Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 15 Canada Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 16 Canada Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 17 Rest of North America Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 19 Rest of North America Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 20 Rest of North America Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 21 UK and European Union Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 23 UK and European Union Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 24 UK and European Union Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 25 UK Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 26 UK Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 27 UK Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 28 UK Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 29 Germany Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 30 Germany Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 31 Germany Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 32 Germany Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 33 Spain Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 34 Spain Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 35 Spain Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 36 Spain Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 37 Italy Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 38 Italy Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 39 Italy Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 40 Italy Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 41 France Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 42 France Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 43 France Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 44 France Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 45 Rest of Europe Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 47 Rest of Europe Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 48 Rest of Europe Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 49 Asia Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 50 Asia Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 51 Asia Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 52 Asia Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 53 China Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 54 China Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 55 China Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 56 China Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 57 Japan Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 58 Japan Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 59 Japan Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 60 Japan Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 61 India Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 62 India Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 63 India Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 64 India Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 65 Australia Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 66 Australia Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 67 Australia Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 68 Australia Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 69 South Korea Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 70 South Korea Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 71 South Korea Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 72 South Korea Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 73 Latin America Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 74 Latin America Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 75 Latin America Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 76 Latin America Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 77 Brazil Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 78 Brazil Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 79 Brazil Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 80 Brazil Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 81 Mexico Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 82 Mexico Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 83 Mexico Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 84 Mexico Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 85 Rest of Latin America Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 87 Rest of Latin America Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 88 Rest of Latin America Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 89 Middle East and Africa Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 91 Middle East and Africa Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 92 Middle East and Africa Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 93 GCC Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 94 GCC Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 95 GCC Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 96 GCC Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 97 Africa Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 98 Africa Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 99 Africa Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 100 Africa Vitrification Market By End-Use, 2022-2032, USD (Million)

  • TABLE 101 Rest of Middle East and Africa Vitrification Market By Specimen, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Vitrification Market By Oocytes, 2022-2032, USD (Million)

TABLE 103 Rest of Middle East and Africa Vitrification Market By Embryo, 2022-2032, USD (Million)

TABLE 104 Rest of Middle East and Africa Vitrification Market By End-Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Vitrification Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Vitrification Market: Quality Assurance
  • FIG. 5 Global Vitrification Market, By Specimen, 2023
  • FIG. 6 Global Vitrification Market, By End-Use, 2023
  • FIG. 7 Global Vitrification Market, By Geography, 2023
  • FIG. 8 Market Geographical Opportunity Matrix - Global Vitrification Market, 2023

FIG. 9Market Positioning of Key Vitrification Market Players, 2023

FIG. 10Global Vitrification Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 11 Global Vitrification Market, By Specimen, 2023 Vs 2032, %
  • FIG. 12 Global Vitrification Market, By End-Use, 2023 Vs 2032, %
  • FIG. 13 U.S. Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 14 Canada Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 15 Rest of North America Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 16 UK Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 17 Germany Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 18 Spain Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 19 Italy Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 20 France Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of Europe Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 22 China Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 23 Japan Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 24 India Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 25 Australia Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 26 South Korea Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Asia Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 28 Brazil Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 29 Mexico Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 30 Rest of Latin America Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 31 GCC Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 32 Africa Vitrification Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Middle East and Africa Vitrification Market (US$ Million), 2022 - 2032
目次
Product Code: 140091-01-24

The vitrification market is expected to grow at a CAGR of 17% during the forecast period of 2024 to 2032. The market's growth is fueled by advancements in ART, increasing demand for IVF procedures, and the expanding acceptance of fertility preservation. However, ethical and legal considerations pose significant restraints, requiring the industry to navigate these complexities responsibly. The market's segmentation, based on specimens, end-use, and geographic dynamics, reflects its adaptability to diverse needs and regional variations. Top players, including Vitrolife AB, Irvine Scientific, and CooperSurgical, exhibit strategies for sustaining market leadership, emphasizing innovation, collaboration, and expansion. As the vitrification market continues to evolve, strategic collaborations, technological advancements, and a commitment to ethical practices will play pivotal roles in shaping the future of assisted reproductive technologies. The industry's focus on meeting the diverse needs of individuals and couples underscores its role in supporting reproductive health and family building, contributing to the broader landscape of healthcare and well-being.

Advancements in Assisted Reproductive Technologies (ART): Oocytes, Embryo, and Sperm Vitrification Leading Innovations

The vitrification market is propelled by continuous advancements in Assisted Reproductive Technologies (ART), with oocytes, embryos, and sperm vitrification leading the charge. Innovations in cryopreservation techniques and vitrification protocols have significantly improved the success rates of fertility treatments. Evidence from clinical studies and industry reports highlights the pivotal role of these advancements in expanding the scope of fertility preservation options. The highest Compound Annual Growth Rate (CAGR) during the forecast period from 2024 to 2032 is anticipated in this segment, reflecting the increasing adoption of vitrification across different stages of the reproductive process. The market responds to the growing demand for precision and effectiveness in fertility treatments by leveraging technological breakthroughs in oocyte, embryo, and sperm vitrification.

Increasing Demand for In Vitro Fertilization (IVF) Procedures: IVF Clinics and Biobanks Catering to Rising Demand

The vitrification market experiences robust growth due to the increasing demand for In Vitro Fertilization (IVF) procedures, with IVF clinics and biobanks playing integral roles. Evidence from patient statistics and industry analyses demonstrates the surge in IVF treatment seeking, driving the need for reliable cryopreservation methods. In 2023, IVF clinics generated the highest revenue, reflecting their central position in providing fertility services. However, the highest CAGR during the forecast period from 2024 to 2032 is expected in the biobanks segment, showcasing the evolving landscape of fertility preservation beyond clinical settings. The market adapts to changing demographics and lifestyle factors, positioning IVF clinics and biobanks as key contributors to meeting the growing demand for assisted reproductive technologies.

Expanding Acceptance of Fertility Preservation: Shifting Societal Trends and Technological Awareness

The vitrification market is driven by the expanding acceptance of fertility preservation, influenced by shifting societal trends and increased technological awareness. Evidence from public health initiatives and changing perspectives on family planning underscores the growing acknowledgment of fertility preservation options. The highest CAGR during the forecast period from 2024 to 2032 is anticipated in this segment, reflecting the market's response to the evolving needs of individuals and couples. As awareness about fertility preservation increases, more people are opting for vitrification to safeguard their reproductive potential. The market aligns with changing societal norms and provides solutions for individuals seeking to preserve their fertility for medical, personal, or lifestyle reasons.

Ethical and Legal Considerations: Balancing Technological Progress with Ethical Standards

A significant restraint in the vitrification market is associated with ethical and legal considerations. Evidence from regulatory frameworks and ethical guidelines highlights the complexities surrounding assisted reproductive technologies. The highest CAGR during the forecast period from 2024 to 2032 is expected in this segment, emphasizing the need for the industry to navigate ethical and legal challenges effectively. As the market continues to evolve, maintaining a balance between technological progress and adherence to ethical standards becomes crucial. The market's response to this restraint involves ongoing dialogues with regulatory bodies, ethical committees, and stakeholders to ensure responsible and inclusive practices. The industry acknowledges the importance of ethical considerations in shaping the future of fertility treatments and vitrification technologies.

Market Analysis by Specimen: Oocyte Vitrification Dominates the Market

The vitrification market is segmented based on specimens, including oocytes, embryos, and sperm. In 2023, the highest revenue was generated from oocyte vitrification, reflecting its prominence in fertility preservation. However, the highest CAGR during the forecast period from 2024 to 2032 is expected in the embryo vitrification segment, indicating the evolving landscape of assisted reproductive technologies. The market addresses diverse fertility preservation needs by offering comprehensive solutions for oocytes, embryos, and sperm, each playing a crucial role in different stages of the reproductive journey. From preserving female fertility to enhancing male reproductive options, the market's segmentation reflects its versatility in meeting the varied needs of individuals and couples.

Market Analysis by End-use: IVF Clinics Dominate the Market

The vitrification market is further segmented based on end-use, including IVF clinics and biobanks. In 2023, IVF clinics led in revenue generation, serving as primary hubs for fertility treatments and vitrification services. However, the highest CAGR during the forecast period from 2024 to 2032 is expected in the biobanks segment, indicating the expanding role of biobanks in fertility preservation beyond clinical settings. The market caters to the diverse needs of individuals and couples by collaborating with both IVF clinics and biobanks, ensuring accessibility and flexibility in fertility preservation services. As the industry evolves, the partnership between IVF clinics and biobanks becomes pivotal in shaping the future landscape of vitrification services.

North America Remains the Global Leader

The vitrification market exhibits diverse geographic trends, with variations in the highest CAGR and revenue percentage across regions. Evidence from market analyses and regional growth patterns sheds light on the global market landscape's dynamics. In 2023, North America led in revenue generation, driven by a high prevalence of fertility treatments and advanced healthcare infrastructure. However, the region with the highest CAGR during the forecast period from 2024 to 2032 is Asia-Pacific, indicating emerging opportunities and evolving trends. The market's geographic segmentation provides strategic insights for market players seeking to capitalize on regional growth, taking into account factors such as regulatory frameworks, cultural nuances, and healthcare accessibility.

Market Competition to Intensify during the Forecast Period

The vitrification market is characterized by intense competition, with top players employing various strategies to sustain market leadership. In 2023, prominent companies such as Vitrolife AB, Irvine Scientific, CooperSurgical, Genea Biomedx, NidaCon International AB, Minitube, IMV Technologies Group, FUJIFILM Corporation, Biotech, Inc., Kitazato Corporation and Shenzhen VitaVitro Biotech demonstrated strong financial performance and market presence. These companies strategically positioned themselves by offering a diverse range of vitrification solutions, investing in research and development to enhance protocol efficacy, and establishing collaborations with fertility clinics and research institutions. The highest revenues for these companies in 2023 position them as industry leaders, and their expected strategies for the forecast period from 2024 to 2032 include further expansion of product portfolios, geographic reach, and collaborative initiatives to address evolving market needs. The market's competitive landscape is marked by continuous innovation and differentiation among key players, ensuring a vibrant and evolving industry that meets the dynamic needs of individuals and couples on their reproductive journey.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofVitrification market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Vitrification market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Specimen

    • Oocytes
  • Devices
  • Kits & Consumables
    • Embryo
  • Devices
  • Kits & Consumables
    • Sperm

End-Use

    • IVF Clinics
    • Biobanks

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Vitrification market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Vitrification market?
  • Which is the largest regional market for Vitrification market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Vitrification market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Vitrification market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Vitrification Market
  • 2.2. Global Vitrification Market, By Specimen, 2023 (US$ Million)
  • 2.3. Global Vitrification Market, By End-Use, 2023 (US$ Million)
  • 2.4. Global Vitrification Market, By Geography, 2023 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2023

3. Vitrification Market: Competitive Analysis

  • 3.1. Market Positioning of Key Vitrification Market Vendors
  • 3.2. Strategies Adopted by Vitrification Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Vitrification Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Vitrification Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Vitrification Market: By Specimen, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Oocytes
      • 5.4.1.1. Devices
      • 5.4.1.2. Kits & Consumables
    • 5.4.2. Embryo
      • 5.4.2.1. Devices
      • 5.4.2.2. Kits & Consumables
    • 5.4.3. Sperm

6. Vitrification Market: By End-Use, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. IVF Clinics
    • 6.4.2. Biobanks

7. North America Vitrification Market, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Vitrification Market: By Specimen, 2022-2032, USD (Million)
  • 7.3. Vitrification Market: By End-Use, 2022-2032, USD (Million)
  • 7.4.Vitrification Market: By Region, 2022-2032, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 7.4.1.1.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 7.4.1.2.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 7.4.1.3.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)

8. UK and European Union Vitrification Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Vitrification Market: By Specimen, 2022-2032, USD (Million)
  • 8.3. Vitrification Market: By End-Use, 2022-2032, USD (Million)
  • 8.4.Vitrification Market: By Region, 2022-2032, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.1.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.2.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.3.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.4.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.5.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 8.4.1.6.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)

9. Asia Pacific Vitrification Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Vitrification Market: By Specimen, 2022-2032, USD (Million)
  • 9.3. Vitrification Market: By End-Use, 2022-2032, USD (Million)
  • 9.4.Vitrification Market: By Region, 2022-2032, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.1.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.2.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.3.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.4.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.5.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 9.4.1.6.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)

10. Latin America Vitrification Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Vitrification Market: By Specimen, 2022-2032, USD (Million)
  • 10.3. Vitrification Market: By End-Use, 2022-2032, USD (Million)
  • 10.4.Vitrification Market: By Region, 2022-2032, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 10.4.1.1.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 10.4.1.2.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 10.4.1.3.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)

11. Middle East and Africa Vitrification Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Vitrification Market: By Specimen, 2022-2032, USD (Million)
  • 11.3. Vitrification Market: By End-Use, 2022-2032, USD (Million)
  • 11.4.Vitrification Market: By Region, 2022-2032, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 11.4.1.1.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 11.4.1.2.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Vitrification Market: By Specimen, 2022-2032, USD (Million)
        • 11.4.1.3.2. Vitrification Market: By End-Use, 2022-2032, USD (Million)

12. Company Profile

  • 12.1. Vitrolife AB
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Irvine Scientific
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. CooperSurgical
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Genea Biomedx
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. NidaCon International AB
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Minitube
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. IMV Technologies Group
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. FUJIFILM Corporation
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Biotech, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Kitazato Corporation
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Shenzhen VitaVitro Biotech
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. Other Notable Players
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives